By Drug Class / Mechanism

NSAID-Based Topical Gel (Diclofenac / Ibuprofen) Market Analysis

Cross-industry research covering NSAID-Based Topical Gel (Diclofenac / Ibuprofen) across 1 market reportspanning Pharmaceuticals.

1 Reports

1 Industries

Reports Covering NSAID-Based Topical Gel (Diclofenac / Ibuprofen)

Medical Cold Gel Market to Reach USD 1.8 Billion by 2033 at 5.2% CAGR

Pharmaceuticals·Market: USD 1.21 Billion (2025)·CAGR: 5.2%

Prescription and OTC NSAID topical gels (notably diclofenac sodium 1% gel, approved under NDA pathways) overlap with the cold gel category in pharmacy positioning. This subsegment grows faster than menthol-only formats as clinical evidence for topical NSAIDs in osteoarthritis strengthens and as payers begin to prefer topical over systemic NSAIDs for elderly patients.

18%

Market Share

5.6%

Segment CAGR

Explore More Segments

Browse all market segments across our research coverage.

View all segments